A carregar...
A phase III randomized controlled trial of radiation dose optimization in non‐Hodgkin lymphoma‐diffuse large B‐cell lymphoma (DOBL study): Study protocol and design
BACKGROUND: Radiation therapy for diffuse large B‐cell lymphoma (DLBCL) has shown improvement in progression free survival. There is uncertainty about the optimal radiation dose, with heterogeneous doses being used, ranging from 30 to 55 Gy. This trial tests the efficacy of using reduced radiation d...
Na minha lista:
| Publicado no: | Cancer Rep (Hoboken) |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7941552/ https://ncbi.nlm.nih.gov/pubmed/32935480 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cnr2.1161 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|